Vitamin D and Type 2 Diabetes - Treat-To-Target
NCT07448974
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study tests whether taking a weekly dose of vitamin D, with the dose adjusted to reach a target blood vitamin D level, can help control blood sugar levels in adults at high risk of developing type 2 diabetes (prediabetes). Research suggests that vitamin D may play a role in blood sugar control. The goal of this study is to see whether adjusting the dose of vitamin D to reach a specific blood vitamin D level improves blood sugar control compared with a placebo (a look-alike pill without vitamin D). One hundred adults aged 30 to 74 with prediabetes will take part.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prediabetes
- Type 2 Diabetes (T2DM)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 30 to 74 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Tufts Medical Center
- Last updated on ClinicalTrials.gov
- August 18, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Tufts Medical Center · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.